Furosemide Zentiva

Quick links

Choose a section

Quick links to important sections

Advertisements

Furosemide Zentiva

Advertisements
Advertisements

Overview of Furosemide Zentiva

Property Description
Active ingredient Furosemid
Form Tablets, Solution for injection
Pharmacological class Loop Diuretic
General purpose Relieving fluid overload/Edema
Origin Synthetic (Sulfonamide derivative)

What Type of Medicine is Furosemide Zentiva?

Furosemide Zentiva is a pharmaceutical preparation containing the potent active substance Furosemid, which is fundamentally classified as a diuretic medicine. It belongs to the loop diuretic class, clinically recognized for its high efficacy and rapid action in promoting fluid removal. Chemically, Furosemid is a synthetic compound derived from anthranilic acid and is part of the broader sulfonamide chemical family. Furosemide Zentiva is frequently supplied as a prescription-only medicine, differentiating its controlled use from over-the-counter preparations.

Furosemide is indicated for the treatment of edema, demonstrating its role in managing conditions characterized by water retention. This medicine is used for managing symptoms related to excess bodily fluid.


What is Furosemide Made of and How is it Given?

The medicinal product is manufactured as a single-ingredient preparation, containing only the active substance Furosemid alongside necessary inactive components. A key differentiating feature is that Furosemide Zentiva is made available in several high-level dosage forms, including tablets for oral administration and a specialized solution for injection suitable for parenteral routes, such as intravenous or intramuscular use. The availability of both forms allows healthcare providers to choose the appropriate route based on the necessity for either convenient, long-term management or a more immediate, rapid physiological response in acute settings.


What is the General Purpose of This Diuretic?

The overall purpose of Furosemide Zentiva is to mitigate the effects of excess bodily fluid by actively promoting a dramatically increased rate of urine output, a process known as diuresis. It achieves this by forcing the kidneys to excrete large quantities of salt, with water naturally following. As a medication, Furosemide works by causing the kidneys to eliminate unnecessary salt and water. This action provides essential relief from fluid overload, thereby decreasing the total volume of fluid circulating in the bloodstream and accumulating in the tissues. The medication's role is therefore to help manage conditions associated with pronounced water retention or swelling (edema).

Regulatory References

  1. Furosemide Vitabalans referral
  2. EMA scientific conclusions
  3. Furosemide Mechanism of Action (NIH)
Advertisements

What side effects are possible with Furosemide Zentiva?

Possible side effects and safety information

The safety profile of Furosemide is formally structured around adverse reactions classified by frequency and effect on physiological systems, as defined by regulatory authorities.

Frequency-Classified Adverse Reactions

The most frequently documented effects relate to the drug's primary action, leading to alterations in fluid and electrolyte balance.

Classification Examples of Documented Effects
Very Common (More than 1 in 10 users) Electrolyte disturbances (e.g., Hypokalemia), Dehydration, Hypovolemia.
Common (1 in 100 to less than 1 in 10) Increased blood creatinine and urea, Hepatic encephalopathy (in patients with pre-existing hepatic impairment).
Uncommon (1 in 1,000 to less than 1 in 100) Hearing disorders (often transient), Tinnitus, Thrombocytopenia.

Serious adverse reactions are also officially documented. These include the rare occurrence of severe hypersensitivity reactions, Acute Pancreatitis, and certain severe dermatological reactions. A specific safety consideration is the risk of ototoxicity (hearing impairment), which is associated with rapid administration or high dosage.

Population-Specific Safety Notes

The regulatory labeling includes specific safety considerations for certain groups. The risk of hepatic encephalopathy is a documented concern for patients with pre-existing hepatic insufficiency. Older adult patients are noted to have an increased susceptibility to dehydration and orthostatic hypotension, which may require cautious monitoring. In infants, particularly premature infants, the development of nephrocalcinosis/nephrolithiasis is a safety consideration.

Safety-Related Restrictions

Furosemide use is officially restricted (contraindicated) in the presence of severe, documented conditions, including Anuria (kidney failure unresponsive to Furosemide), Hepatic coma, Severe Hypovolemia or Dehydration, and documented Severe Hypokalemia or Hyponatremia.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official overdose information for Furosemide Zentiva focuses on the severe physiological consequences resulting from excessive diuresis and the required emergency actions.

Feature Official Regulatory Statements
Documented overdose presentations Profound diuresis leading to dehydration (hypovolemia), marked hypotension (low blood pressure), and severe electrolyte disturbances, specifically Hypokalemia, Hyponatremia, and Hypochloremic alkalosis. Other signs include drowsiness, apathy, thirst, weakness, and muscular cramps.
Physiological systems affected The overdose profile includes effects on the Cardiovascular system (circulatory collapse, cardiac arrhythmias), Renal system (acute renal failure), and Neurological system (coma in severe cases) [1.4, 2.10].
Population-specific overdose notes Elderly patients are noted to be particularly vulnerable to complications like vascular thrombosis and embolism due to excessive fluid loss. In patients with pre-existing hepatic cirrhosis, overdose may precipitate hepatic encephalopathy [1.4, 2.10].
Emergency-response statements The official guidance mandates to seek immediate medical attention for any suspected overdose. No specific antidote is known for Furosemide [1.1].

Official overdose statements:

  • Overdose may be severe or life-threatening due to complications such as hypovolemic shock [1.4, 2.10].
  • Management is described as symptomatic and supportive, requiring the correction of fluid and electrolyte imbalances (e.g., sodium, potassium, and blood volume) [1.1, 2.5].
  • Frequent monitoring of serum electrolytes, vital signs, and renal function is required during supportive treatment [1.1, 1.4].

Connection to the overall overdose profile

The regulatory profile defines overdose as an acute event requiring urgent response due to the rapid development of critical fluid and circulatory deficiencies. Because life-threatening outcomes can occur, official labeling clearly mandates that individuals seek immediate medical attention and confirms that management involves intensive monitoring and physical correction of these severe physiological imbalances.

Advertisements

Therapeutic Uses of Furosemide Zentiva

Furosemide Zentiva is generally used for managing symptoms related to systemic imbalance, primarily pronounced fluid retention or edema.

The medication is used to treat excess fluid held in body tissues caused by various medical problems. Its use is considered relevant for conditions marked by increased physiological stress, including Congestive Heart Failure, chronic kidney disorders, and Liver Cirrhosis with associated ascites. This supportive action provides assistance by helping the body quickly excrete excess water and salt, which eases physical discomfort and may support improved comfort during periods of heightened symptoms.


This medicine is used in situations involving certain distressing symptoms, contributing to the management of symptom clusters such as peripheral swelling, internal congestion (like pulmonary edema), and volume-driven high blood pressure. It is commonly used when short-term symptomatic assistance is needed, relevant in clinical settings marked by temporary physiological imbalance, and is applied across conditions where functional stability becomes affected.

“This approach provides supportive relief that may assist with maintaining a sense of stability when symptoms are more noticeable.”

Quick Fact: Support for Pronounced Swelling (Edema)

Relief from Systemic and Peripheral Edema

This medicine is commonly used across conditions presenting with systemic or localized discomfort of fluid retention, including peripheral swelling in the legs, feet, and ankles. It assists in managing these symptoms, which contributes to improved comfort and stability by helping to ease the overall symptom load of physical swelling.

Management of Internal Congestion and Acute Fluid Crises

The medication is commonly used for managing internal fluid accumulation, such as internal congestion in the lungs (pulmonary edema) where symptoms related to organ-specific functional stress are present. It is often applied during acute symptomatic episodes, such as sudden decompensated heart failure. Its use helps address symptom clusters that may become intense or disruptive, providing supportive relief that may assist with maintaining a sense of stability when symptoms are more noticeable.

Supportive Control of Volume-Driven Hypertension

Furosemide Zentiva is relevant for easing symptoms related to heightened physiological activity, such as elevated blood pressure, in situations where systemic fluid imbalance is a factor. This supportive action contributes to easing the overall symptom load and helps improve day-to-day comfort during symptomatic periods associated with chronic cardiovascular challenges.

Regulatory References

  1. MedlinePlus Drug Information overview on Furosemide
Advertisements

Eligibility and Restrictions for Use

Furosemide Zentiva eligibility is defined by official regulatory labeling, outlining specific populations who are prohibited from use and those who require conditional monitoring.

Absolute Contraindications

The medicine must not be used in individuals with anuria (kidney failure resulting in no urine production), known hypersensitivity to furosemide or other sulfonamide derivatives, severe hypovolaemia or dehydration, and severe electrolyte imbalances such as hypokalemia or hyponatremia. Patients experiencing hepatic coma and pre-coma are also strictly contraindicated.

Age-Specific and Conditional Eligibility

Population Group Regulatory Status
Adults Approved for labeled indications.
Pediatric Patients Approved for edema, though specific formulations may be not recommended for adolescents.
Older Adults Use requires caution, reflecting potentially slower elimination.
Pregnancy Use only if potential benefit justifies risk.
Lactation Generally contraindicated as it may inhibit milk production.

Use is restricted and requires caution in patients with impaired renal function, impaired hepatic function (cirrhosis), partial urinary tract obstruction, diabetes mellitus, and gout.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Furosemide's interaction profile requires specific restrictions and careful management due to its potent effects on electrolytes and renal function.

Contraindicated and High-Risk Combinations

The co-administration of Furosemide and Ethacrynic Acid is generally restricted due to the significant risk of ototoxicity (inner ear damage). The risk of ototoxicity is also markedly enhanced when Furosemide is combined with other ototoxic agents, such as Aminoglycoside antibiotics or Cisplatin, particularly in individuals with impaired renal function.

Pharmacodynamic and Electrolyte Interactions

The combination with other antihypertensive medicines (e.g., ACE inhibitors, ARBs) may lead to severe hypotension, often necessitating the temporary cessation or reduction of Furosemide prior to initiating or increasing the partner drug's dose. Furosemide-induced potassium loss may potentiate the toxicity of Digitalis glycosides and may be exacerbated by concomitant use of other hypokalemia-causing agents, such as corticosteroids or licorice in large amounts. Concomitant use with Lithium requires close monitoring as Furosemide reduces lithium clearance, posing a high risk of lithium toxicity.

Interactions Affecting Exposure

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may attenuate the diuretic effect of Furosemide. Agents like Probenecid and high-dose Salicylates may interfere with the renal secretion of Furosemide, potentially reducing its effectiveness. Phenytoin is documented to decrease Furosemide's bioavailability.

Advertisements

Mechanism of Action

How Furosemide Zentiva works

Furosemide Zentiva is a loop diuretic that modulates fluid balance by targeting the kidneys. Its mechanism centers on inhibiting a specific protein pump located in the renal tubules.


Blocking the Kidney's Salt Pump (NKCC2)

The drug functions as a selective inhibitor of the Na^+/ K^+/2 Cl^- cotransporter (NKCC2). This transporter resides in the thick ascending limb of the loop of Henle. By binding to this protein, furosemide blocks the reabsorption of ions, specifically sodium and chloride, from the tubular fluid back into the bloodstream.


Initiating the Osmotic Diuresis Cascade

Blocking the NKCC2 transporter prevents salt reabsorption, causing the unabsorbed ions to remain in the kidney tubule. This elevated solute concentration initiates an osmotic cascade that draws water into the urine. This process modifies the molecular steps of water regulation, resulting in an increase in urine volume (diuresis).


Modulating Circulatory Fluid Volume

This loss of fluid through diuresis directly leads to a reduction in the total circulating plasma volume within the blood vessels. This systemic effect engages mechanisms that modulate the body's overall fluid status, resulting in a physiological adjustment in fluid load.

Advertisements

Dosage and Administration Information

General Instructions for Administration and Dosing

Furosemide Zentiva is administered via specific routes and dose regimens according to established clinical guidelines. The selection of route and dose is based on the patient's condition and the necessity for rapid action.


Administration Property Guideline
Route of Administration Indicated for Oral administration (tablets, liquid) for routine use, or Intravenous (IV) injection for acute conditions. The Intramuscular (IM) route is reserved for exceptional circumstances.
Standard Adult Oral Dose Initial dosing typically ranges from 20 mg to 80 mg once daily. Doses are individualized (titrated) to achieve the minimum effective dose, with a maximum recommended dose of up to 600 mg per day in severe cases.
Dose Frequency and Timing Oral doses are generally taken once daily in the morning. If a second dose is necessary, it is taken at midday or early afternoon. Administration after 4 PM is generally avoided to prevent nocturnal diuresis.
Intravenous (IV) Rate The intravenous injection is administered slowly over 1 to 2 minutes. For controlled high-dose infusion in adults, a rate not exceeding 4 mg per minute is advised.
Timing with Food/Other Drugs Oral tablets may be taken with or without food. Furosemide is typically taken at least 2 hours before or 2 hours after sucralfate to maintain drug absorption.
Population-Specific Rules The initial dose for pediatric patients is typically determined by weight, often 1 mg per kg of body weight. Older adults require slow dose titration as drug elimination may be slower.

Procedural Note

If an oral dose is missed, it is taken as soon as remembered. However, if it is already late in the day (e.g., after 4 PM), the missed dose is skipped, and the regular morning schedule resumed. Parenteral use is intended for short-term acute management and is transitioned to the oral route as soon as practical.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Furosemide Zentiva

Evidence for use in Edema associated with Heart, Liver, and Kidney Conditions

Research has examined Furosemide Zentiva's use in conditions characterized by systemic or functional imbalance, specifically where there is a buildup of fluid, or edema, linked to heart failure, liver cirrhosis, or certain kidney diseases. The evidence base includes short-term Randomized Controlled Trials (RCTs) and various observational studies. These studies monitored outcomes related to physical discomfort, such as the visible reduction of swelling, and measured changes in body weight and urinary output over defined time intervals.

Studies reported findings describing patterns observed in the fluid balance of the observed populations. Researchers measured how symptoms evolved in the people studied, particularly regarding the measured movement of fluid. However, the specific findings were mixed and varied depending on the patient's underlying condition. When considering the full context of the research, evidence for sustained fluid control patterns remains limited. Long-term effects are not fully established, and there is limited information for changes measured beyond the initial few weeks or months.

Evidence for use in Hypertension (High Blood Pressure)

Furosemide Zentiva was evaluated in studies exploring its use in high blood pressure, often as part of a combination therapy alongside other medications, rather than as a single treatment. The research primarily consists of clinical trials and longer-term observational studies. Studies explored outcomes related to physiological strain, specifically focusing on measurements of systolic and diastolic blood pressure over short and intermediate timeframes.

Observational data gathered over several years contributed to the broader evidence landscape, describing patterns in patient cohorts where this medication was part of the ongoing assessment plan. A key research limitation is that the available evidence mainly explores Furosemide Zentiva as a component of a combination regimen, meaning comparative evidence is lacking against many of the newer blood pressure medications or for its use alone.

What is Still Uncertain About Furosemide Zentiva Research

The overall evidence contributes to the broader evidence landscape, but significant areas of uncertainty remain. Data for certain groups remain insufficient, particularly for patients with multiple complex conditions, and long-term effects are not fully established regarding sustained outcomes over many years. Furthermore, the evidence quality varies across studies, and the generalizability of some findings may be limited because the results apply only to the populations studied under those specific research conditions.

Key Studies & References

  1. Diuretic therapy in chronic kidney disease
  2. Management of edema in patients with cirrhosis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Furosemide Zentiva (FAQ)


Q: How quickly should someone expect Furosemide Zentiva to start working?

A: Following oral administration, the increase in urine output typically begins within about one hour after the oral dose is taken. Official regulatory documents indicate that the strongest effect is usually observed during the first or second hour.


Q: How long does the primary effect of Furosemide Zentiva usually last?

A: Regulatory documents state that the diuretic effect of an oral dose of Furosemide typically lasts for 6 to 8 hours. This duration is noted in the regulatory documents.


Q: Is Furosemide Zentiva considered a 'water pill'?

A: Furosemide is classified as a diuretic, which is why it is often referred to informally as a “water pill.” Its main purpose, according to official information, is to increase the amount of water and salt the body removes through the kidneys, which helps reduce excess fluid retention.


Q: What is the difference between Furosemide and Furosemide Zentiva?

A: Furosemide is the name of the generic active substance that provides the medicinal effect. Furosemide Zentiva is a specific pharmaceutical preparation of this generic substance. Regulatory bodies generally ensure that all approved generic versions are equivalent to brand-name versions in terms of safety and effect.


Q: What does 'Zentiva' refer to in the drug name?

A: Zentiva refers to the manufacturer's name or brand used to identify their specific pharmaceutical preparation of the generic drug Furosemide. This naming convention helps distinguish the product manufactured by this company from other versions of the same generic drug.


Q: Why is Furosemide Zentiva sometimes described as a high-ceiling diuretic?

A: The term "high-ceiling" diuretic is used in medical descriptions derived from regulatory data to describe Furosemide's classification. It refers to the drug's ability to induce a profound diuretic effect—meaning a high maximum or 'ceiling' response—by blocking ion reabsorption in the kidney's loop of Henle.


Q: What is the distinction between Furosemide Zentiva and other diuretics like hydrochlorothiazide?

A: Furosemide is classified as a loop diuretic that acts in the loop of Henle in the kidney. This mechanism results in a strong diuretic effect and allows it to maintain effectiveness even in the presence of impaired kidney function, unlike some other diuretic types such as thiazide diuretics.


Q: What is the difference between edema and ascites, which Furosemide Zentiva may treat?

A: Edema is a general term for swelling caused by fluid retention anywhere in the body. Ascites is a specific type of edema characterized by fluid buildup in the abdomen, and Furosemide is commonly used in its management, especially when related to liver disease.


Q: Is Furosemide Zentiva intended for occasional use or daily use?

A: The oral tablet is typically prescribed for daily maintenance therapy in chronic conditions such as edema or high blood pressure. While the injectable form is used for acute situations, the oral form is generally used as part of an ongoing, consistent regimen.


Q: Is Furosemide Zentiva commonly used after hospital discharge for fluid retention?

A: Furosemide is often administered as an injectable agent for managing severe fluid overload in hospitalized patients. This clinical practice often leads to the prescription of the oral version of Furosemide Zentiva to continue necessary fluid management after discharge.


Q: Is it common to feel dizzy or lightheaded after taking Furosemide Zentiva?

A: Dizziness or lightheadedness is a commonly reported effect that may occur while taking Furosemide Zentiva. This is often related to changes in fluid volume or blood pressure. Official information states that observation for these symptoms is recommended.


Q: Is it normal to feel thirsty while using Furosemide Zentiva?

A: Feeling thirsty and having a dry mouth are explicitly listed in the official safety information. These are signs or symptoms of fluid or electrolyte imbalance.


Q: Does Furosemide Zentiva typically cause muscle cramps or weakness?

A: Muscle pains or cramps and general muscular weakness are listed in regulatory documents as signs associated with potential fluid or electrolyte imbalance. This can be particularly linked to low potassium levels, known as hypokalemia, which is a known effect of this type of medication.


Q: What are the signs that Furosemide Zentiva might be causing dehydration?

A: Signs and symptoms that may indicate excessive fluid loss, and potentially dehydration, are documented in the official safety information. These include a feeling of thirst, dryness of mouth, weakness, and lethargy.


Q: Can Furosemide Zentiva cause skin rash or itching?

A: Rash and itching are listed in official product safety information as possible side effects. While they are usually minor, they can sometimes be signs of a rare but serious hypersensitivity reaction.


Q: Are there documented cases of Furosemide Zentiva affecting stomach upset?

A: Official safety information includes reports of gastrointestinal side effects. Nausea, vomiting, diarrhea, and stomach irritation or cramping are listed as documented adverse reactions, though the frequency varies.


Q: Does taking Furosemide Zentiva make someone more sensitive to the sun?

A: Regulatory documents indicate that the skin of some patients may be more sensitive to the effects of sunlight while taking Furosemide. Official patient counseling states that patients should be aware of this possibility.


Q: What are the most common reasons a person might have to stop taking Furosemide Zentiva?

A: Official labeling indicates that the drug may be discontinued if a patient develops severe electrolyte imbalances or significant dehydration. Other reasons for stopping relate to a lack of effectiveness or the occurrence of a serious adverse reaction.


Q: What kind of monitoring is typically involved when a person starts Furosemide Zentiva?

A: Official information requires close medical supervision when starting this medicine. Monitoring typically involves frequent checks of serum electrolytes (like potassium), creatinine, and BUN to assess kidney function and fluid balance.


Q: Why is it important to check blood chemistry when using Furosemide Zentiva?

A: Checking blood chemistry is important because Furosemide affects fluid and electrolyte balance in the body, and imbalances can be common. Official information states that serum electrolytes (like potassium), creatinine, and BUN should be determined frequently at the start of therapy and periodically thereafter to monitor for potential changes.


Q: How is the long-term safety of Furosemide Zentiva described in regulatory documents?

A: While the full safety profile is documented, studies have indicated that long-term effects regarding sustained outcomes over many years are not fully established. For chronic use, official labeling requires continued monitoring for potential risks like electrolyte imbalance and changes in renal function.


Q: Are there any known interactions between Furosemide Zentiva and alcohol?

A: Official guidance warns against drinking alcohol while taking Furosemide Zentiva. This is due to the potential for alcohol to further lower blood pressure, which may increase the risk of dizziness and dehydration.


Q: Can Furosemide Zentiva affect blood sugar levels?

A: Regulatory documents indicate that Furosemide may increase blood glucose (sugar) levels in some patients. For this reason, official information mentions that blood glucose monitoring is recommended for patients with diabetes.


Q: Can Furosemide Zentiva be taken at the same time as thyroid medication?

A: Regulatory interaction data indicates that high doses of Furosemide used together with a thyroid medication like levothyroxine may temporarily change the effects of the thyroid hormone. Official information suggests that monitoring of thyroid hormone levels may be needed for some patients.


Q: Does Furosemide Zentiva interact with common herbal supplements?

A: Regulatory information specifically notes that co-administration with licorice in large amounts may increase the risk of low potassium. Comprehensive information on all other common herbal supplements is not explicitly detailed in the main regulatory documents.


Q: Is it necessary to drink a specific amount of water when taking Furosemide Zentiva?

A: General official guidance suggests drinking normally while on the medicine. However, for patients with underlying conditions such as heart failure or kidney problems, fluid intake may need to be limited, and this requires medical guidance.


Q: Are there any common foods or drinks that should be avoided with Furosemide Zentiva?

A: Official sources generally warn against drinking alcohol as it may cause a further drop in blood pressure. Co-administering large amounts of licorice is also noted as it may increase the risk of low potassium levels. Any specific dietary concerns should be addressed with a healthcare provider.

Advertisements

How should Furosemide Zentiva be stored and disposed of?

How to Store and Dispose of Furosemide Zentiva

Official regulatory documents define strict environmental and safety requirements for storing and disposing of this medication.

Storage Requirements

Condition Requirement
Temperature Do not store above the maximum temperature specified (e.g., 25 C or 30 C).
Protection Keep the medicine in its original package to protect it from light and moisture.
Child Safety Keep out of the sight and reach of children.
Stability Do not use the product after the expiry date printed on the packaging. Specific in-use stability periods apply to solutions after opening or dilution.

Disposal Instructions

Regulatory labeling mandates that Furosemide Zentiva must not be disposed of via household waste or by flushing down the toilet. Any unused or expired medicine must be returned to a pharmacy or local pharmaceutical waste collection scheme to protect the environment, in accordance with official local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Furosemide Zentiva found in:

A-Z Index: